The purpose of this study is to develop and evaluate the acceptability of a novel feature for use with the prescription digital therapeutic reSET-O.~This feature aims to improve the quality of treatment for opioid use disorder (OUD) patients starting buprenorphine initiation at home by providing new digital content and withdrawal symptom assessment to support them during this process.~This study will evaluate the acceptability of this new feature and assess success of at-home buprenorphine initiation.
The purpose of this study is to assess feasibility of an at-home digital therapy designed to support buprenorphine initiation and adherence.